↵* rs69833267 heterozygous do not have increased risk of thyroid cancer (see tables 1 and 4).
↵† ORs and frequencies for the 9q22 markers were obtained from the diplotype analysis presented in table 3. Population frequency from non-carriers, heterozygous and homozygous carriers is shown in table 3.